(Q40506379)

21 September 2017

Apomorphine delays simple reaction time in Parkinsonian patients (English)

1 reference

21 September 2017

1 reference

1 reference

1

Thomas Müller

1 reference

21 September 2017

Sabine Benz

2

1 reference

PubMed ID

15177065

21 September 2017

Horst Przuntek

series ordinal

3

1 reference

21 September 2017

1 June 2002

1 reference

21 September 2017

4

1 reference

Parkinsonism and Related Disorders

inferred from page(s)

published in

1 reference

21 September 2017

8

1 reference

21 September 2017

5

1 reference

21 September 2017

357-360

1 reference

Simple and choice reaction time and the use of advance information for motor preparation in Parkinson's disease

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Usefulness of movement time in the assessment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

The neurobiological basis of movement initiation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

A meta-analysis on cognitive slowing in Parkinson's disease: are simple and choice reaction times differentially impaired?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Sleep attacks and Parkinson's disease treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Sleep episodes in Parkinson's disease: a wake-up call.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Sleep attacks in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Challenge tests to predict the dopaminergic response in untreated Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Domperidone and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Core assessment program for intracerebral transplantations (CAPIT)

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Effect of practice on performance of a skilled motor task in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Preparation of manual movements in hemiparkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Reaction time in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Cognitive components of reaction time in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Movement amplitude choice reaction time performance in Parkinson's disease may be independent of dopaminergic status

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Reaction time and movement velocity abnormalities in Parkinson's disease under different task conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Motor response to repeated dopaminergic stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Apomorphine doses impair the reaction time of fast reacting but not slow reacting rats

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Fluctuations in plasma dopamine level impair memory in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Dose-dependent memory impairment in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Pharmacologic strategies for augmenting cognitive performance in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

The pharmacology of memory.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Dopaminergic modulation of cholinergic responses in rat medial prefrontal cortex: an electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Apomorphine induced cognitive changes in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Dopamine Auto- and Postsynaptic Receptors: Electrophysiological Evidence for Differential Sensitivity to Dopamine Agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Blockade of apomorphine-induced yawning in rats by the dopamine autoreceptor antagonist (+)-AJ 76.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Electroencephalographic correlates of the sedative effects of dopamine agonists presumably acting on autoreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

Dopamine autoreceptor function is lost in advanced Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2801%2900046-3

7 January 2021

10.1016/S1353-8020(01)00046-3

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

15177065